Norwich Pharmaceuticals Inc.
FDA Approved Drugs

Norwich Pharmaceuticals Inc.

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued RX Unclassified
  • Total Records 13
  • Latest Approval Date Jun 17, 2026
  • Data Source FDA
  • First Approval Date Apr 21, 1993
All
13
View
Unclassified
1
View
Discontinued
3
View
RX
9
View
Company Overview

Company

Norwich Pharmaceuticals Inc.

Country

U.S.A

Website

Visit Website

Email

info@norwichpharma.com

Social Profiles

Company Snapshot

Norwich Pharmaceuticals Inc.

6826 NY-12, Norwich, NY 13815

U.S.A

www.norwichpharma.com/ info@norwichpharma.com View on Map
FDA Approved Drug Records ( 13 records )
1993
21 Apr
Discontinued Application: 20198

Drug Name

ADALAT CC

Product Number

1

Dosage Form

-

Strength

30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1993-04-21

20198 / 1

Active Ingredient

NIFEDIPINE

Application Number

20198

Product Number

1

Dosage Form

-

Strength

30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1993-04-21

Regulatory Status

Discontinued

1993
21 Apr
Discontinued Application: 20198

Drug Name

ADALAT CC

Product Number

2

Dosage Form

-

Strength

60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1993-04-21

20198 / 2

Active Ingredient

NIFEDIPINE

Application Number

20198

Product Number

2

Dosage Form

-

Strength

60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1993-04-21

Regulatory Status

Discontinued

1993
21 Apr
Discontinued Application: 20198

Drug Name

ADALAT CC

Product Number

3

Dosage Form

-

Strength

90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1993-04-21

20198 / 3

Active Ingredient

NIFEDIPINE

Application Number

20198

Product Number

3

Dosage Form

-

Strength

90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1993-04-21

Regulatory Status

Discontinued

2026
17 Jun
RX Application: 217449

Drug Name

BALOXAVIR MARBOXIL

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2026-06-17

217449 / 1

Active Ingredient

BALOXAVIR MARBOXIL

Application Number

217449

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2026-06-17

Regulatory Status

RX

2026
17 Jun
RX Application: 217449

Drug Name

BALOXAVIR MARBOXIL

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2026-06-17

217449 / 2

Active Ingredient

BALOXAVIR MARBOXIL

Application Number

217449

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2026-06-17

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-08-25

214547 / 1

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-08-25

214547 / 2

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2023-08-25

214547 / 3

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

2023-08-25

214547 / 4

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

4

Dosage Form

-

Strength

40MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

5

Dosage Form

-

Strength

50MG

Approval Date

2023-08-25

214547 / 5

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

5

Dosage Form

-

Strength

50MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

6

Dosage Form

-

Strength

60MG

Approval Date

2023-08-25

214547 / 6

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

6

Dosage Form

-

Strength

60MG

Approval Date

2023-08-25

Regulatory Status

RX

2023
25 Aug
RX Application: 214547

Drug Name

LISDEXAMFETAMINE DIMESYLATE

Product Number

7

Dosage Form

-

Strength

70MG

Approval Date

2023-08-25

214547 / 7

Active Ingredient

LISDEXAMFETAMINE DIMESYLATE

Application Number

214547

Product Number

7

Dosage Form

-

Strength

70MG

Approval Date

2023-08-25

Regulatory Status

RX

-
Unclassified Application: 214369

Drug Name

RIFAXIMIN

Product Number

1

Dosage Form

-

Strength

550MG

Approval Date

-

214369 / 1

Active Ingredient

RIFAXIMIN

Application Number

214369

Product Number

1

Dosage Form

-

Strength

550MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    13 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
13 total
  • Discontinued
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ADALAT CC

Application Number

20198

Product Number

1

Active Ingredient

NIFEDIPINE

Dosage Form

-

Strength

30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit